| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 78,362 | 93,035 | 110,930 | 75,154 |
| Marketable debt securities, at fair value | 186,314 | 229,761 | 143,600 | 244,383 |
| Accounts receivable, net | 87,302 | 80,134 | 82,984 | 38,718 |
| Inventory | 6,356 | 5,875 | 5,548 | 4,090 |
| Prepaid expenses and other current assets | 34,347 | 28,760 | 28,048 | 17,222 |
| Total current assets | 392,681 | 437,565 | 371,110 | 379,567 |
| Long-term inventory | 30,698 | 30,280 | 31,999 | 33,590 |
| Property and equipment, net | 3,627 | 4,022 | 4,320 | 4,561 |
| Operating lease right of use assets | 9,668 | 10,576 | 11,464 | 12,336 |
| Intangible assets, net | 110,038 | 113,868 | 109,435 | 105,607 |
| Other assets | 8,476 | 8,880 | 10,253 | 19,648 |
| Total assets | 555,188 | 605,191 | 538,581 | 555,309 |
| Convertible debt, current portion | NaN | 0 | 0 | 68,838 |
| Accounts payable | 12,912 | 24,800 | 18,225 | 19,134 |
| Accrued expenses | 104,408 | 126,035 | 105,762 | 81,682 |
| Operating lease liabilities, current portion | 6,017 | 5,875 | 5,734 | 5,595 |
| Other current liabilities | 2,100 | 3,194 | 5,353 | 14,291 |
| Total current liabilities | 125,437 | 159,904 | 135,074 | 189,540 |
| Convertible debt, less current portion | NaN | 311,724 | 311,370 | 311,016 |
| Convertible debt | 312,079 | NaN | NaN | NaN |
| Operating lease liabilities, less current portion | 9,566 | 11,134 | 12,645 | 14,124 |
| Other non-current liabilities | 9,378 | 7,601 | 5,928 | 7,882 |
| Total liabilities | 456,460 | 490,363 | 465,017 | 522,562 |
| Common stock 0.0001 par value 200,000,000 shares authorized 92,403,744, and 90,922,868 issued and outstanding as of march 31, 2026 and december 31, 2025, respectively | 9 | 9 | 9 | 9 |
| Additional paid-in capital | 1,609,596 | 1,588,721 | 1,550,051 | 1,534,698 |
| Accumulated deficit | -1,509,815 | -1,472,713 | -1,475,442 | -1,501,148 |
| Accumulated other comprehensive loss | -1,062 | -1,189 | -1,054 | -812 |
| Total stockholders' equity | 98,728 | 114,828 | 73,564 | 32,747 |
| Total liabilities and stockholders' equity | 555,188 | 605,191 | 538,581 | 555,309 |
Travere Therapeutics, Inc. (TVTX)
Travere Therapeutics, Inc. (TVTX)